Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dhairya International is an Indian pharmaceutical export company headquartered in Mumbai, specializing in the global supply of generic and branded medications. The firm provides a comprehensive portfolio of products, including oncology drugs, HIV/AIDS treatments, hepatitis medications, and various life-saving specialty pharmaceuticals. Beyond finished formulations like tablets and injections, the company also distributes active pharmaceutical ingredients (APIs) and surgical supplies. Dhairya International primarily serves international markets, acting as a bridge between Indian manufacturing capabilities and global healthcare needs. Their business model focuses on wholesale distribution and merchant exporting rather than proprietary drug discovery or development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dhairya International.